Tinea Corporis Industry Research Report - Global Forecast till 2023

1. Tinea Corporis Industry Treatment Synopsis 2019 Clinical Development, Statistics Growth Analysis to 2023 Tinea corporis is contagious infection which can spread from one person to other hence it is important not to share towel, flannels, bathmats with another person. Market Synopsis Global Tinea Corporis Industry is expected to rise steadily at a CAGR of 7.2% during forecast period of 2018- 2023. Tinea corporis is a fungal infection that is caused by tinea rubrum, trichophyton mentagrophytes and epidermophyton floccosum fungi. This fungal infection mainly occurs in humid climatic condition. It is also known as ringworm infection. Tinea corporis infection occurs mostly on arms, legs or can also occur on different parts of body. The global Tinea Corporis Industry is expected to see the growth in upcoming year due to entry of new drug product in market for treatment. Many key players in market are engaged in development of new drug product for tinea corporis treatment. Avail Free Sample at https://www.marketresearchfuture.com/sample_request/6838 Market Segmentation: Global Tinea Corporis Industry is segmented into drug type, diagnosis, treatment and end-users. Tinea Corporis Industry on basis of drug types is segmented into antifungals, steroids and anti-infective combinations. Global Tinea Corporis Industry by Drug Type • • • Antifungals Steroids Anti-Infective Combinations Global Tinea Corporis Industry, by Diagnosis • • Physical Exam Imaging Tests o o o o o Wood lamp (black light) examination Microscopy using potassium hydroxide (KOH) Fungal culture Skin biopsy Others Global Tinea Corporis Industry, by Treatment • • • • Antifungal shampoos Antifungal creams Drugs Others Global Tinea Corporis Industry, by End-Users • • • Hospital Pharmacies Drug Stores Online Pharmacies Market Research Future Pune, India.

2. • • Dermatology hospitals Others Top Industry Key players: Some of the key players in the global Tinea Corporis Industry are Teva Pharmaceuticals, Inc., Glenmark Pharmaceuticals Inc, NorthStar Rx LLC, Aurobindo Pharma Limited, and Camber Pharmaceuticals, Inc., AvKare, Inc., Novartis AG, Sebela Pharmaceuticals, Inc., Bayer AG, Blueberry Therapeutics Ltd, Perrigo Company, Taro Pharmaceuticals., Inc., Breckenridge Pharmaceutical, Inc. Browse https://www.marketresearchfuture.com/reports/tinea-corporis-market-6838 Complete Premium Research Report Enabled with TOC at Regional Market Summary Geographically, the America holds the highest market share for Tinea Corporis Industry and the reason being many market players are engaged in development of new drug product innovation, and as this infection is more prone to humid climatic condition there is an increasing prevalence of fungal infection in this region. Whereas increasing awareness of fungal disease and rising healthcare expenditure by the government are some of the factors responsible for growth of market in this region Europe is expected to be the second largest market in the globe owing to the increasing aging population, increasing prevalence of fungal infection, focus on aesthetic appearance, increasing research base. Whereas rise in susceptible immune compromised patient population is responsible for market growth in this region. Asia-Pacific is anticipated to be the fastest growing market owing to the growing prevalence of fungal infection, changing lifestyle, increase in population, increasing healthcare expenditure by government are some of the factor responsible for market growth in this region. LIST OF TABLES Table 1 Global Tinea Corporis Industry Synopsis, 2018–2023 Table 2 Global Tinea Corporis Industry Estimates and Forecast, 2018–2023 (USD Million) Table 3 Global Tinea Corporis Industry, By Region, 2018–2023 (USD Million) Table 4 Global Tinea Corporis Industry, By Drug Type, 2018–2023 (USD Million) Table 5 Global Tinea Corporis Industry, By Diagnosis, 2018–2023 (USD Million) Table 6 Global Tinea Corporis Industry, By Treatment, 2018–2023 (USD Million) Table 7 Global Tinea Corporis Industry, By End-Users, 2018–2023 (USD Million0 …Continues. Get an Amazing Discount at https://www.marketresearchfuture.com/check-discount/6838 Intended Audience • • • • Manufacturers and Suppliers Hospitals and Clinics Laboratories and Associations Research Institutes Market Research Future Pune, India.

3. • Dermatology Clinics About Market Research Future: we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. Contact: Market Research Future +1 646 845 9312 Email: sales@marketresearchfuture.com Market Research Future Pune, India.